BioSpace News Archive

Business

Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) will release its fourth-quarter and full-year 2021 financial results on Wednesday, Feb. 23, 2022.

February 3, 2022

·

1 min read

Deals

Vimian Group Acquires Supplier of Veterinary Surgical Products in New Zealand and Australia

Vimian Group has signed an agreement to acquire Kahu Vet Group, a supplier of veterinary surgical products in New Zealand and Australia.

February 3, 2022

·

3 min read

Genetown

GRO Biosciences to Present at 2022 BIO CEO & Investor Conference

GRO Biosciences Inc., an emerging biotechnology company leveraging groundbreaking science to expand the amino acid alphabet and deliver on the promise of protein therapeutics, announced that it will present at the 2022 BIO CEO & Investor Conference.

February 3, 2022

·

1 min read

Biotech Beach

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences - Feb 03, 2022

Zentalis Pharmaceuticals, Inc. announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis, will participate in fireside chats at two upcoming virtual investor conferences.

February 3, 2022

·

2 min read

Pharm Country

Trevena to Present at the 2022 BIO CEO & Investor Conference

Trevena, Inc. announced that Carrie Bourdow, President & CEO, will present a corporate overview at the BIO CEO & Investor Conference being held from February 14th - 17th, 2022.

February 3, 2022

·

1 min read

Business

Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates

Mersana Therapeutics, Inc. announced a research collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover novel ADCs for three targets.

February 3, 2022

·

5 min read

Policy

Pardes Biosciences Announces FDA Clearance of IND Application for PBI-0451, an Oral Antiviral Drug Candidate for the Treatment and Prevention of SARS-CoV-2 Infections

Pardes Biosciences, Inc. announced that its Investigational New Drug application for PBI-0451 has been cleared by the United States Food and Drug Administration.

February 3, 2022

·

4 min read

Business

Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, February 9, 2022

Anavex Life Sciences Corp. announced that it will issue financial results for its fiscal quarter ended December 31, 2021 on Wednesday, February 9, 2022.

February 3, 2022

·

3 min read

Biotech Beach

Kintara Therapeutics Announces Issuance of New US Patent Related to VAL-083 and MGMT Resistance: Implications for Targeting Brain Tumor Stem Cells

Kintara Therapeutics, Inc. today announced that the U.S. Patent and Trademark Office has issued to Kintara United States Patent No. 11,234,955 covering a method of treating brain tumors.

February 3, 2022

·

4 min read

Intrivo Launches The On/Go™ Advanced Care Toolkit (ACT) To Support Those Who Test Positive For COVID-19

Intrivo, a U.S.-based health-tech leader, launched the beta version of its On/Go Advanced Care Toolkit (ACT), a one-of-a-kind rapid-testing support solution available for free in the On/Go mobile app exclusively for people who use the company’s On/Go COVID-19 Antigen Self-Test.

February 3, 2022

·

4 min read